Published in Am J Pathol on November 01, 1998
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Cancer Res (2008) 2.87
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol (2001) 2.68
Mixed epithelial and stromal tumors of the kidney. A report of 22 cases. Virchows Arch (2004) 1.80
The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS Genet (2014) 1.74
Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res (2009) 1.55
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell (2007) 1.53
Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia. EMBO J (2000) 1.44
Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas. Am J Surg Pathol (2013) 1.42
Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol (2012) 1.37
TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov (2014) 1.19
ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer (2013) 1.18
Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol (2010) 1.15
Myofibrosarcoma. Virchows Arch (2004) 1.13
The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. Mol Cell Biol (2006) 1.10
Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands. Head Neck Pathol (2013) 1.08
Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms. Am J Pathol (2000) 1.05
A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off. Head Neck Pathol (2016) 1.03
Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features. Virchows Arch (2011) 1.01
COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans. J Mol Diagn (2000) 1.01
Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion. Mod Pathol (2016) 1.00
Congenital mesoblastic nephroma: Clinical analysis of eight cases and a review of the literature. Oncol Lett (2014) 1.00
Genomic characteristics of soft tissue sarcomas. Virchows Arch (2009) 0.99
RNA-Seq mapping and detection of gene fusions with a suffix array algorithm. PLoS Comput Biol (2012) 0.95
Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch (2009) 0.93
Primary colonic congenital infantile fibrosarcoma presenting as meconium peritonitis. Pediatr Surg Int (2008) 0.92
DNA methylation profile distinguishes clear cell sarcoma of the kidney from other pediatric renal tumors. PLoS One (2013) 0.88
AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts. Cancer Chemother Pharmacol (2012) 0.88
The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor. Proc Natl Acad Sci U S A (2005) 0.87
Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes. Genes Chromosomes Cancer (2015) 0.85
Unusual morphology in mesoblastic nephroma. Pediatr Surg Int (2008) 0.84
TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts. Cancer Chemother Pharmacol (2014) 0.82
Mammary analog secretory carcinoma of the parotid gland: A case report and literature review. Int J Surg Case Rep (2015) 0.82
Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma. Head Neck Pathol (2014) 0.81
Primary renal sclerosing epithelioid fibrosarcoma: report of 2 cases with EWSR1-CREB3L1 gene fusion. Am J Surg Pathol (2015) 0.78
Directing oncogenic fusion genes into stem cells via an SCL enhancer. Proc Natl Acad Sci U S A (2005) 0.78
Regression of a congenital mesoblastic nephroma. Pediatr Blood Cancer (2010) 0.77
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model. Cancer Lett (2016) 0.76
Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma. Cold Spring Harb Mol Case Stud (2015) 0.76
Newly described salivary gland tumors. Mod Pathol (2017) 0.75
InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data. PLoS One (2016) 0.75
Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers. Biomark Cancer (2016) 0.75
Molecular basis of differentiation therapy for soft tissue sarcomas. Trends Cancer Res (2016) 0.75
Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review). Int J Mol Med (2014) 0.75
Antenatally detected solid tumour of kidney. BMJ Case Rep (2014) 0.75
Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod Pathol (2017) 0.75
[Solid pediatric tumors : A brief survey of the rarity cabinet]. Pathologe (2017) 0.75
Chromosomal translocations in human cancer. Nature (1994) 6.44
The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med (1994) 4.65
Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell (1994) 4.64
A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet (1998) 3.41
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet (1997) 3.11
trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell (1991) 2.97
Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood (1997) 2.75
Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron (1994) 2.44
In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry (1988) 2.26
Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med (1991) 1.99
The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci U S A (1996) 1.98
Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet (1997) 1.95
Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol (1996) 1.93
Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J Neurosci (1995) 1.85
Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms' tumor. Pediatrics (1967) 1.84
The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res (1995) 1.73
Infantile fibrosarcoma. Cancer (1976) 1.28
p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Oncogene (1996) 1.19
Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations. Am J Pathol (1995) 1.13
Fetal hamartoma of kidney. A benign, symptomatic, congenital tumor, not a form of Wilms' tumor. Am J Clin Pathol (1969) 1.09
Fibrosarcoma in infants and children. Cancer (1962) 1.03
Congenital mesoblastic nephroma of infancy. Perspect Pediatr Pathol (1973) 0.99
So-called congenital-infantile fibrosarcoma: does it exist and what is it? Pediatr Pathol (1994) 0.98
Nonrandom numerical chromosome aberrations (+8, +11, +17, +20) in infantile fibrosarcoma. Cancer Genet Cytogenet (1989) 0.94
Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms' Tumor Study. J Pediatr Surg (1982) 0.93
Fibrosarcoma in infants and children. Application of new techniques. Am J Surg Pathol (1994) 0.92
Congenital mesoblastic nephroma: a clinicoradiologic study of 17 cases representing the pathologic spectrum of the disease. J Pediatr (1987) 0.91
Neonatal renal tumors. J Pediatr Surg (1970) 0.90
Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma. Arch Pathol Lab Med (1986) 0.89
Mesoblastic nephromas: a study of 29 tumours from the SIOP nephroblastoma file. Histopathology (1985) 0.87
Malignant mesenchymal nephroma of infancy: report of a case with pulmonary metastases. Am J Surg Pathol (1980) 0.86
Consistent numerical chromosome aberrations in congenital fibrosarcoma. Cancer Genet Cytogenet (1993) 0.86
Cytogenetic investigation of a case of congenital fibrosarcoma. Cancer Genet Cytogenet (1989) 0.86
Chromosome aberrations in mesoblastic nephroma. Am J Pathol (1993) 0.85
Fibrosarcomas in infants and children. J Pediatr Surg (1970) 0.85
Primary renal tumours in the first year of life. A population based review. Virchows Arch A Pathol Anat Histopathol (1983) 0.84
Cytogenetic analysis of a congenital fibrosarcoma. Cancer Genet Cytogenet (1991) 0.84
Congenital fibrosarcoma. Cancer (1967) 0.83
Infantile and adult fibrosarcomas of the soft tissues. Acta Pathol Jpn (1979) 0.82
Cytogenetic characterization of congenital or infantile fibrosarcoma. Eur J Pediatr (1991) 0.82
Trisomy 11 and other nonrandom trisomies in congenital fibrosarcoma. Cancer Genet Cytogenet (1994) 0.79
Fibrosarcoma in early infancy. Pathol Eur (1973) 0.78
Ultrastructural, immunocytochemical, and cytogenetic characterization of a large congenital fibrosarcoma. Arch Pathol Lab Med (1992) 0.78
Deletion of part of the short arm of chromosome 17 in a congenital fibrosarcoma. Cancer Genet Cytogenet (1990) 0.78
Presence or absence of trisomy 11 is correlated with histologic subtype in congenital mesoblastic nephroma. Cancer Genet Cytogenet (1994) 0.78
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell (1986) 8.53
Symptoms and suffering at the end of life in children with cancer. N Engl J Med (2000) 6.75
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med (1997) 6.03
Barbiturates in the care of the terminally ill. N Engl J Med (1992) 5.42
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res (2001) 5.40
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 5.22
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42
Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol (1989) 4.37
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol (2000) 3.92
PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science (2000) 3.87
Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res (1985) 3.44
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene (2001) 3.36
Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell (1992) 3.30
Risk of internal cancers from arsenic in drinking water. Environ Health Perspect (2000) 3.29
Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A (1997) 3.22
BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene (2007) 3.19
The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem (1987) 3.13
The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells (1998) 3.13
BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol (2001) 3.12
Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore (2004) 3.01
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol (2000) 2.99
Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97
Arsenic and cancers. Lancet (1988) 2.93
Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995. Optom Vis Sci (1999) 2.93
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev (2000) 2.90
Heterogeneity of kinase inhibitor resistance mechanisms in GIST. J Pathol (2008) 2.85
Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol (2001) 2.82
Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. JAMA (2000) 2.81
Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res (1995) 2.75
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol (2001) 2.68
Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology (1997) 2.61
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A (2001) 2.54
A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer (1986) 2.37
Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis (1990) 2.30
Chromosome aberrations in desmoid tumors. Trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet (1995) 2.29
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med (2001) 2.26
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst (2000) 2.23
Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol (1994) 2.17
Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell (1995) 2.15
Cytology of typical and atypical Ewing's sarcoma/PNET. Am J Clin Pathol (1996) 2.14
Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst (2001) 2.11
Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet (2001) 2.09
Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev (2000) 2.07
An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell (1988) 2.01
Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med (1991) 1.99
Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect (2000) 1.98
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet (1998) 1.96
Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol (1998) 1.85
Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.84
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway. Oncogene (2007) 1.84
Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol (1997) 1.83
Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology (2000) 1.82
Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke (1997) 1.81
Sudden infant death syndrome in relation to weather and optimetrically measured air pollution in Taiwan. Pediatrics (1995) 1.79
Epidemiologic study of the prevalence and severity of myopia among schoolchildren in Taiwan in 2000. J Formos Med Assoc (2001) 1.79
Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg (1997) 1.76
Prenatal detection of neuroblastoma: a ten-year experience from the Dana-Farber Cancer Institute and Children's Hospital. Pediatrics (1993) 1.74
HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol (1999) 1.74
Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med (2000) 1.72
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer (1996) 1.71
Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res (1997) 1.69
Hepatitis B virus markers in Chinese twins. Anticancer Res (1989) 1.68
The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer (1992) 1.68
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer (1995) 1.66
Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer (1995) 1.65
Prenatal detection of a Wilms' tumor. Pediatr Radiol (1999) 1.62
Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet (1999) 1.61
Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience. J Pediatr Hematol Oncol (2000) 1.60
Control of severe pain in children with terminal malignancy. J Pediatr (1995) 1.58
Characterization of the hgbA locus encoding a hemoglobin receptor from Haemophilus ducreyi. Infect Immun (1995) 1.56
Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res (1995) 1.56
Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy. Clin Infect Dis (1999) 1.56
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol (2000) 1.56
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol (1989) 1.55
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev (2001) 1.54
Acalculous cholecystitis in children. J Pediatr Surg (1996) 1.52
Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol (1993) 1.51
Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity. Cancer (1995) 1.49
Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol (1999) 1.48
Cardiac synovial sarcoma with translocation (X;18) associated with asbestos exposure. Cancer (1994) 1.48
Gains of chromosome 8 are confined to mesenchymal components in pleuropulmonary blastoma. Pediatr Dev Pathol (2002) 1.48
Mortality attributable to cigarette smoking in Taiwan: a 12-year follow-up study. Tob Control (1998) 1.47
Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol (1998) 1.45
Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol (1999) 1.44
Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus (1996) 1.44
Childhood soft tissue sarcoma: a 20-year experience. J Pediatr (1997) 1.44